» Articles » PMID: 25853259

Patient and Provider Concordance on Symptoms During the Oncology Outpatient Clinic Visit

Overview
Specialties Critical Care
Oncology
Date 2015 Apr 9
PMID 25853259
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cancer patients experience multiple symptoms, with specific symptoms varying by cancer type. Problems in communication between patients and health care providers (HCPs) can interfere with effective symptom assessment and management.

Objective: To address gaps in previous research by prospectively examining concordance between HCPs and patients on identifying patients' symptoms by using an identical tool for patients and HCPs at the time of the oncology clinic visit.

Methods: 94 patients completed measures of symptom experience and medical comorbidities before seeing their oncology medical team. HCPs were informed of a patient's participation in the study before seeing the patient in clinic. Immediately after the clinic visit, HCPs completed a symptom survey in which they noted the patient's symptoms.

Results: Patients reported more symptoms than the HCPs endorsed. The highest level of concordance for any symptom fell in the moderate agreement range. Kappa values reflecting concordance between patients and HCPs were not significantly different between the various patient-HCP pairs. No demographic or clinical variables for patients were found to be statistically related to the level of agreement on patients' symptoms.

Limitations: The use of a small convenience sample size drawn from 3 specialty oncology outpatient clinics may limit the generalizability of the results to other types of cancer. The distribution of cancer stage was weighted toward stages III and IV, likely contributing to the number of symptoms.

Conclusions: The level of agreement between HCPs and oncology patients on patient symptoms is weak. Concordance levels were similar, regardless of the type of HCP.

Citing Articles

Remote Patient-Reported Outcomes and Activity Monitoring to Improve Patient-Clinician Communication Regarding Symptoms and Functional Status: A Randomized Controlled Trial.

Parikh R, Schriver E, Ferrell W, Wakim J, Williamson J, Khan N JCO Oncol Pract. 2023; 19(12):1143-1151.

PMID: 37816198 PMC: 10732505. DOI: 10.1200/OP.23.00048.


The relationship between response style and symptom reporting in cancer patients.

Deshields T, Penalba V, Arroyo C, Tan B, Tippey A, Amin M Support Care Cancer. 2023; 31(5):312.

PMID: 37126138 DOI: 10.1007/s00520-023-07761-z.


Who are the patients being offered the faecal immunochemical test in routine English general practice, and for what symptoms? A prospective descriptive study.

Calanzani N, Pannebakker M, Tagg M, Walford H, Holloway P, de Wit N BMJ Open. 2022; 12(9):e066051.

PMID: 36123111 PMC: 9486301. DOI: 10.1136/bmjopen-2022-066051.


Digital Health Applications in Oncology: An Opportunity to Seize.

Parikh R, Basen-Enquist K, Bradley C, Estrin D, Levy M, Lichtenfeld J J Natl Cancer Inst. 2022; 114(10):1338-1339.

PMID: 35640986 PMC: 9384132. DOI: 10.1093/jnci/djac108.


Patient and clinician nudges to improve symptom management in advanced cancer using patient-generated health data: study protocol for the PROStep randomised controlled trial.

Parikh R, Ferrell W, Wakim J, Williamson J, Khan N, Kopinsky M BMJ Open. 2022; 12(5):e054675.

PMID: 35551088 PMC: 9109034. DOI: 10.1136/bmjopen-2021-054675.